Saturday, October 27, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Pharmaceutical regulatory failure must be remedied
Longmont Daily Times-Call
While investigations are ongoing in the fungal meningitis outbreak that has sickened more than 300 Americans and killed 24, it's clear that the regulatory system that oversees pharmaceutical compounding failed and needs to be strengthened. The steroid ...
See all stories on this topic »
Pharmaceutical company Boehringer Ingelheim to pay $95 million settlement
Milwaukee Journal Sentinel (blog)
State and federal governments will be receiving a $95 million boost from a pharmaceutical company accused of improperly marketing four drugs and paying doctors kickbacks as an incentive to prescribe the drugs. The money comes from a settlement that ...
See all stories on this topic »
Israeli pharmaceutical giant Teva gets FDA approval for leukemia drug
Haaretz
Israeli pharmaceutical giant Teva gets FDA approval for leukemia drug. Synribo, also known as omacetaxine mepesuccinate, treats a type of chronic myelogenous leukemia in patients whose cancer has progressed after treatment with at least two drugs from ...
See all stories on this topic »

Haaretz
5 Pharmaceutical Stocks to Sell Now
Investorplace.com
The ratings of five Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). This week, Flamel Technologies (NASDAQ:FLML) falls to a D ("sell"), worse than ...
See all stories on this topic »
Fla. pharmaceutical company shut down
WKMG Orlando
The Florida Department of Health (DOH) Friday, issued an Emergency Suspension Order (ESO) against Rejuvi Pharmaceuticals, Inc. The order shuts down the Boca Raton business from operating as a community drug compounding pharmacy in the state of ...
See all stories on this topic »
Telenor signs up with Sun Pharma's Valia
Hindu Business Line
Telenor Group will sell 26 per cent stake in its new Indian venture to Sun Pharmaceutical's Executive Director Sudhir Valia. The new entity, Telewings Communications Pvt Ltd, has signed a partnership agreement with Lakshdeep Investments & Finance Pvt ...
See all stories on this topic »

Hindu Business Line
Watson Receives FDA Approval for Generic Actos; Forest Labs in Settlement Pact
Equities.com
Watson Pharmaceuticals, Inc. (NYSE: WPI) announced Watson has launched a generic version of Actos® (Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets) after receiving final approval today from the U.S. FDA. Watson began shipping the product ...
See all stories on this topic »
CIPMMA adopts resolution opposing DCGI's order seeking to stop brand based ...
pharmabiz.com
The executive committee of the Consortium of Indian Pharmaceutical Manufacturers & Marketers Association (CIPMMA), an association of manufacturers of branded pharmaceutical products, has strongly condemned the DCGI's order saying that the ...
See all stories on this topic »
Valeant Pharmaceuticals Price Target Lowered to $67.00 at Paradigm Capital ...
Zolmax
Valeant Pharmaceuticals logo Valeant Pharmaceuticals (NYSE: VRX) had its price target lowered by Paradigm Capital to $67.00 in a research report sent to investors on Wednesday morning. "We continue to hold a positive view toward Valeant's unique ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost